Literature DB >> 18467330

Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD.

Minying Zhang1, Xuefeng Wu, Andrew J Lee, Wei Jin, Mikyoung Chang, Ato Wright, Tadaatsu Imaizumi, Shao-Cong Sun.   

Abstract

The IkappaB kinase (IKK)-related kinases, IKKepsilon and TBK1, participate in the induction of type I interferons (IFNs) during viral infections. Deregulated activation of IKKepsilon and TBK1 also contributes to the abnormal cell survival and transformation. However, how these kinases are negatively regulated remains unclear. We show here that the tumor suppressor CYLD has an essential role in preventing aberrant activation of IKKepsilon/TBK1. CYLD deficiency causes constitutive activation of IKKepsilon/TBK1, which is associated with hyper-induction of IFNs in virus-infected cells. We further show that CYLD targets a cytoplasmic RNA sensor, RIG-I, and inhibits the ubiquitination of this IKKepsilon/TBK1 stimulator. Consistent with the requirement of ubiquitination in RIG-I function, CYLD potently inhibits RIG-I-mediated activation of the IFN-beta promoter. These findings establish CYLD as a key negative regulator of IKKepsilon/TBK1 and suggest a role for CYLD in the control of RIG-I ubiquitination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467330      PMCID: PMC2441564          DOI: 10.1074/jbc.M801451200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex.

Authors:  R T Peters; S M Liao; T Maniatis
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

2.  Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha.

Authors:  G Xiao; M E Cvijic; A Fong; E W Harhaj; M T Uhlik; M Waterfield; S C Sun
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

Review 3.  Function of RIG-I-like receptors in antiviral innate immunity.

Authors:  Mitsutoshi Yoneyama; Takashi Fujita
Journal:  J Biol Chem       Date:  2007-03-29       Impact factor: 5.157

4.  Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.

Authors:  Hans Häcker; Vanessa Redecke; Blagoy Blagoev; Irina Kratchmarova; Li-Chung Hsu; Gang G Wang; Mark P Kamps; Eyal Raz; Hermann Wagner; Georg Häcker; Matthias Mann; Michael Karin
Journal:  Nature       Date:  2005-11-23       Impact factor: 49.962

5.  Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription.

Authors:  M Bonnard; C Mirtsos; S Suzuki; K Graham; J Huang; M Ng; A Itié; A Wakeham; A Shahinian; W J Henzel; A J Elia; W Shillinglaw; T W Mak; Z Cao; W C Yeh
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

6.  NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.

Authors:  J L Pomerantz; D Baltimore
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

7.  NAK is an IkappaB kinase-activating kinase.

Authors:  Y Tojima; A Fujimoto; M Delhase; Y Chen; S Hatakeyama; K Nakayama; Y Kaneko; Y Nimura; N Motoyama; K Ikeda; M Karin; M Nakanishi
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

Review 8.  TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.

Authors:  Roberto Baccala; Kasper Hoebe; Dwight H Kono; Bruce Beutler; Argyrios N Theofilopoulos
Journal:  Nat Med       Date:  2007-05       Impact factor: 53.440

9.  CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.

Authors:  Eirini Trompouki; Eudoxia Hatzivassiliou; Theodore Tsichritzis; Hannah Farmer; Alan Ashworth; George Mosialos
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

10.  IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.

Authors:  Katherine A Fitzgerald; Sarah M McWhirter; Kerrie L Faia; Daniel C Rowe; Eicke Latz; Douglas T Golenbock; Anthony J Coyle; Sha-Mei Liao; Tom Maniatis
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

View more
  72 in total

1.  Cell signaling. Anchors away for ubiquitin chains.

Authors:  Kislay Parvatiyar; Edward W Harhaj
Journal:  Science       Date:  2010-06-04       Impact factor: 47.728

2.  A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response.

Authors:  Suzanne Paz; Myriam Vilasco; Steven J Werden; Meztli Arguello; Deshanthe Joseph-Pillai; Tiejun Zhao; Thi Lien-Anh Nguyen; Qiang Sun; Eliane F Meurs; Rongtuan Lin; John Hiscott
Journal:  Cell Res       Date:  2011-01-04       Impact factor: 25.617

3.  A non-canonical role of the p97 complex in RIG-I antiviral signaling.

Authors:  Qian Hao; Shi Jiao; Zhubing Shi; Chuanchuan Li; Xia Meng; Zhen Zhang; Yanyan Wang; Xiaomin Song; Wenjia Wang; Rongguang Zhang; Yun Zhao; Catherine C L Wong; Zhaocai Zhou
Journal:  EMBO J       Date:  2015-10-15       Impact factor: 11.598

Review 4.  Activation of RIG-I-like receptor signal transduction.

Authors:  Annie M Bruns; Curt M Horvath
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-11-08       Impact factor: 8.250

Review 5.  Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.

Authors:  Francisca E Reyes-Turcu; Karen H Ventii; Keith D Wilkinson
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

6.  The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon.

Authors:  Chen Wang; Taoyong Chen; Jia Zhang; Mingjin Yang; Nan Li; Xiongfei Xu; Xuetao Cao
Journal:  Nat Immunol       Date:  2009-05-31       Impact factor: 25.606

Review 7.  Pathogen recognition and inflammatory signaling in innate immune defenses.

Authors:  Trine H Mogensen
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

Review 8.  CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.

Authors:  S-C Sun
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

Review 9.  Ubiquitylation in innate and adaptive immunity.

Authors:  Vijay G Bhoj; Zhijian J Chen
Journal:  Nature       Date:  2009-03-26       Impact factor: 49.962

Review 10.  Emerging roles for the non-canonical IKKs in cancer.

Authors:  R R Shen; W C Hahn
Journal:  Oncogene       Date:  2010-11-01       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.